Exploring the Growth and Challenges of Medical Marijuana Inc., a Leading Cannabis Innovator

Abstract

Medical Marijuana Inc. Industry: Medical Marijuana Company: Medical Marijuana Inc. Introduction The medical marijuana industry deals with the manufacture and sales of legalized medicinal cannabis. It is an industry growing rapidly, with global sales expected to hit $33.6 billion by 2025. However, though research has defined the economic impact that the marijuana industry has on the worldwide economy, most notably on the American economy, where most states have legalized marijuana use; the industry is experiencing a complex legal landscape that limits the industry’s potential to conduct research and confirm the health benefits associated with marijuana use. Such limitations hinder the general acceptance of cannabis for medicinal use like any other drug, significantly affecting the industry’s global development and growth. Medical marijuana inc. is one of the dominating companies in America within the cannabis industry, with its headquarters in [City, State]. It is a holding company with various subsidiaries that enhance its medicinal cannabis operations for its target customer. Different bodies own the medical marijuana Inc. with Bennicas & Associates holding 60,000 shares and taking the lead in its ownership. Medical marijuana inc. is an investment holding company that operates in the cannabinoid-based nutraceutical industry (Vélez-Torres, Hurtado, and Bueno, 2021). It is a company that focuses on the development, sale, and distribution of hemp oil that is purely made from natural cannabis. Therefore, one can argue that this is a cannabis product research and development company. Its owner incorporated the company in 2005 and reported massive growth regardless of the negative perception that many people have towards marijuana, both for medical and recreational use. Though its headquarters are in [City, State], its primary subsidiaries enhance success in delivering its primary operations to the larger American target customers. Medical Marijuana Inc. is involved in researching and developing therapeutic agents designed to reduce oxidative stress, treat pain and other medical disorders through chewing-gum-based cannabinoid medical products (Vélez-Torres, Hurtado, and Bueno, 2021). The company advocates for the legalization of medical marijuana, citing its benefits on skin and healthcare, especially in preventing, fighting, and managing terminal illnesses like cancer. Industries Financials In an income statement by Yahoo finance, it is open that the company has total revenue of $33 445 thousand. The revenue costs stand at $10,241 thousand, giving a gross profit of $23 204 thousand (Data derived from multiple sources or calculated by Yahoo Finance). While considering the valuation measures, the market cap as of 2019 was at 54.49 million, with an enterprise value of 62.53millions (calculated by Yahoo Finance). The financial highlights for the Fiscal Year-End 30 December 2019 defined a profit margin of 14.91%, assumed to have increased based on the development and growth levels that the industry has expressed for the past two years. The operating margin for the trailing twelve months stood at -3.76%, which has reported a positive impact based on the current rate of development and growth within the medicinal marijuana industry. The company stock price stands at US $ 0.02, translating from $0.0174-0.0002 (-1.14%). On 31 December 2020 was 10.38 million and 6.32m by 31 December 2021, which is a decrease attributed to the COVID-19 pandemic...